evra 203mg, contraception treatment

What is EVRA?

EVRA is an effective contraception administered in the form of a patch, which is a transdermal delivery system.  

The patch is applied to the skin, and it releases a controlled amount of norelgestromin and ethinyl oestradiol into the bloodstream over a specified period.  

This method offers an alternative to oral contraceptives, providing a more convenient and consistent way to deliver the hormones. Users typically apply a new patch once a week for three weeks, followed by a patch-free week to allow for menstruation. The patch's adherence to the skin facilitates continuous and reliable hormone absorption, contributing to its efficacy as a contraceptive method. 

What is EVRA used to treat?

EVRA is a combined hormonal contraceptive used to prevent pregnancy. Its transdermal patch form delivers two active substances, norelgestromin and ethinyl oestradiol, which work together to regulate the menstrual cycle and inhibit ovulation. By adhering to the skin, the patch provides a convenient and consistent method for hormone absorption. It is important to use EVRA as directed by a healthcare professional to ensure its effectiveness as a contraceptive measure.

Who can and cannot use medicines containing EVRA?

EVRA is a transdermal contraceptive patch designed to prevent pregnancy. While it is an effective option for many, certain medical conditions may warrant careful consideration before use. 

Discussing your complete medical history with your healthcare provider ensures personalised advice and optimal usage of this contraceptive method. 

Who should not use EVRA

EVRA is not suitable for individuals with a history of blood clots, heart attacks, strokes, angina pectoris, or specific migraines. Conditions such as severe diabetes, high blood pressure, high cholesterol, liver diseases, and certain cancers (breast, womb, cervix, or vagina) require alternative contraceptive options. 

Individuals with a history of deep vein thrombosis, pulmonary embolism, or those awaiting surgery or prolonged immobility should use caution. Conditions like Crohn's disease, ulcerative colitis, SLE (a type of lupus), and HUS (a rare but serious kidney condition) may also mean you should consider an alternative contraception method to EVRA.  

It may not be suitable for women who smoke and who are 35 or over, or who weigh 90kg (14 stone) or more. 

Special attention is needed for those with sickle cell anaemia, hypertriglyceridemia, and a family history of elevated fat levels in the blood. Factors like obesity, older age (especially beyond 35 years), recent childbirth, and inflammation in veins or varicose veins require thorough evaluation. 

Signs of blood clots

Recognising signs of potential blood clots is crucial, including swelling, pain, or tenderness in the leg, sudden breathlessness, coughing, chest pain, and severe abdominal pain. 

Monitoring and regular check-ups: 

Regular medical check-ups and monitoring are recommended, especially for those with specific medical conditions like diabetes, epilepsy, or liver problems.   

contraception image 3, woman applying a patch on her arm

How to use EVRA patch?

Apply your first patch and wear it for 7 days. On day 8, change the patch to a new one. Change it like this every week for 3 weeks, and then have a patch-free week.  

During your patch-free week you'll get a withdrawal bleed, like a period, although this may not always happen.  

After 7 patch-free days, apply a new patch and start the 4-week cycle again. Start your new cycle even if you're still bleeding.   

Spread the cost with paypal pay in 3

Frequently asked questions